60
Participants
Start Date
October 17, 2025
Primary Completion Date
January 8, 2027
Study Completion Date
November 2, 2027
ALXN2420
ALXN2420 will be administered via subcutaneous (SC) injection
Placebo
Placebo will be administered via SC injection.
Research Site, Budapest
Research Site, Budapest
Research Site, Copenhagen
Research Site, Odense
Research Site, Szeged
Research Site, Pécs
Research Site, New York
Research Site, Genoa
Research Site, Milan
Research Site, Cona
Research Site, Ann Arbor
Research Site, Pisa
Research Site, Napoli
Research Site, Las Vegas
Research Site, Los Angeles
Research Site, Los Angeles
Research Site, Torrance
Research Site, Portland
Research Site, Messina
Research Site, Beijing
Research Site, Shanghai
Research Site, Cluj-Napoca
Research Site, Guangzhou
Research Site, Kunming
Research Site, Boston
Research Site, Buenos Aires
Research Site, Buenos Aires
Research Site, CABA
Research Site, Ciudad de Buenos Aires
Research Site, Curitiba
Research Site, Ribeirão Preto
Research Site, Rio de Janeiro
Research Site, São Paulo
Research Site, Roma
Research Site, Kaunas
Research Site, Vilnius
Research Site, Leiden
Research Site, Rotterdam
Research Site, Gliwice
Research Site, Krakow
Research Site, Warsaw
Research Site, Wroclaw
Research Site, Bucharest
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY